Similarly, Xu et al. found miR-143 downregulation in prostate cancer cells, and miR-143 overexpression suppressed cell proliferation and enhanced prostate cancer cell sensitivity to docetaxel by targeting KRAS 23. Here, KRAS is linked to prostate cancer.